Mount Sinai Health System has begun implementing a cloud-native platform that will integrate global cancer insights and use artificial intelligence to streamline pathology processes.It's working with the genomic technology firm Sophia Genetics, which announced the new collaboration on Thursday at the American Association for Cancer Research annual meeting in San Diego.WHY IT MATTERSMount Sinai, a National Cancer Institute-designated Comprehensive Cancer Center, supports care for more than 4,000
Breach alerts and compliance intelligence — before the workday starts.
